• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
              Advocacy & Research for Unlimited Lifespans

- - - - -

Fructose is bad. Carbotoxicity and how to avoid it.

fructose carbs ketogenic diet acarbose metformin d-glucosamine luteolin

  • Please log in to reply
No replies to this topic

#1 tunt01

  • Guest, Advisor
  • 2,305 posts
  • 410
  • Location:NW

Posted 06 November 2018 - 05:01 PM

Kroemer G, e. (2018). Carbotoxicity-Noxious Effects of Carbohydrates. - PubMed - NCBI Ncbi.nlm.nih.gov. Retrieved 6 November 2018, from https://www.ncbi.nlm.../?term=30340032


Kroemer G1López-Otín C2Madeo F3de Cabo R4.


Modern nutrition is often characterized by the excessive intake of different types of carbohydrates ranging from digestible polysaccharides to refined sugars that collectively mediate noxious effects on human health, a phenomenon that we refer to as "carbotoxicity." Epidemiological and experimental evidence combined with clinical intervention trials underscore the negative impact of excessive carbohydrate uptake, as well as the beneficial effects of reducing carbs in the diet. We discuss the molecular, cellular, and neuroendocrine mechanisms that link exaggerated carbohydrate intake to disease and accelerated aging as we outline dietary and pharmacologic strategies to combat carbotoxicity.





    • the first steps of glycolysis are under feedback regulation inhibiting excessive glucose utilization,
  • FRUCTOSE catabolism is unrestrained
    • allowing for limitless utilization of fructose carbons for gluconeogenesis, lactate production, acetyl-CoA synthesis, and consequent lipogenesis (Lim et al., 2010). Hence, fructose is highly lipogenic
    • magnified with saturated fat intake









  • inhibits alpha-glucosidase an enzyme that reduces the breakdown of complex carbs
  • acarbose effectiveness linked to shift in microbiome (Gu et al 2017)
  • legumes contain natural inhibitors alpha-glucosidase and alpha-amylase




  • inhibits sodium/glucose cotransporter 2 (SGLT2)
    • prevents recover of glucose from kidney (ends up being urinated out)
    • dapaglifozin is anti-hypertensive, anti-diabetic



  • glycolysis inhibitor
  • MOA (?)



  • Inhibits mitochondrial isoform of GDPH
    • GDPH catalyzes conversion of of G3P to DHAP
      • inhibition blocks gluconeogenesis
    • GDPH KO mice re-capitulate the effects of metformin
    • Metformin is not a Complex I inhibitor, so much as it is actually a GDPH inhibitor that localizes in the liver (see Madiraju, Shulman, et al 2014, 2018)


"tempting to speculate that metformin inhibits the accumulation of AGEs due to its capacity to inhibit GPDH and hence to deplete DHAP as well as methylglyoxal, an effect that has been observed in diabetic patients (Beisswenger et al., 1999). However, metformin has also been shown to increase the expression and activity of the enzyme that detoxifies methylglyoxal, which is glyoxalase 1 (Glo1) (Kender et al., 2014)"


Edited by tunt01, 06 November 2018 - 05:05 PM.

  • Informative x 1

Also tagged with one or more of these keywords: fructose, carbs, ketogenic diet, acarbose, metformin, d-glucosamine, luteolin

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users